| Primary |
| Atrial Fibrillation |
47.4% |
| Drug Use For Unknown Indication |
19.1% |
| Product Used For Unknown Indication |
9.1% |
| Hypertension |
6.1% |
| Type 2 Diabetes Mellitus |
2.2% |
| Atrial Flutter |
1.7% |
| Thrombosis |
1.7% |
| Hypothyroidism |
1.3% |
| Prevention |
1.3% |
| Ventricular Fibrillation |
1.3% |
| Benign Prostatic Hyperplasia |
0.9% |
| Blood Pressure |
0.9% |
| Glaucoma |
0.9% |
| Hyperlipidaemia |
0.9% |
| Osteoporosis |
0.9% |
| Psoriasis |
0.9% |
| Renal Failure Chronic |
0.9% |
| Stent Placement |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
| Thyroid Disorder |
0.9% |
|
| Cardiac Failure Congestive |
10.9% |
| International Normalised Ratio Increased |
7.8% |
| Renal Failure |
7.8% |
| Atrial Fibrillation |
6.3% |
| Torsade De Pointes |
6.3% |
| Xanthopsia |
6.3% |
| Alanine Aminotransferase Increased |
4.7% |
| Dyspnoea |
4.7% |
| Malaise |
4.7% |
| Nausea |
4.7% |
| Off Label Use |
4.7% |
| Syncope |
4.7% |
| Weight Increased |
4.7% |
| Blood Creatinine Increased |
3.1% |
| Cardiac Failure |
3.1% |
| Drug Ineffective |
3.1% |
| Fatigue |
3.1% |
| Glomerular Filtration Rate Decreased |
3.1% |
| Intestinal Haemorrhage |
3.1% |
| Irritability |
3.1% |
|
| Secondary |
| Atrial Fibrillation |
42.5% |
| Drug Use For Unknown Indication |
12.3% |
| Hypertension |
7.8% |
| Product Used For Unknown Indication |
6.8% |
| Arrhythmia |
4.1% |
| Atrial Flutter |
4.1% |
| Cerebrovascular Accident Prophylaxis |
2.7% |
| Arthralgia |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
| Extrasystoles |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Hypothyroidism |
1.8% |
| Benign Prostatic Hyperplasia |
1.4% |
| Cardiac Disorder |
1.4% |
| Cardiac Failure Congestive |
1.4% |
| Dyslipidaemia |
1.4% |
| Ventricular Tachycardia |
1.4% |
| Arrhythmia Prophylaxis |
0.9% |
| Back Pain |
0.9% |
| Blood Glucose Abnormal |
0.9% |
|
| Feeling Abnormal |
10.0% |
| Irritability |
8.0% |
| Renal Failure Chronic |
8.0% |
| Arrhythmia |
6.0% |
| Nausea |
6.0% |
| Pain In Extremity |
6.0% |
| Pulmonary Arterial Hypertension |
6.0% |
| Weight Increased |
6.0% |
| Atrial Fibrillation |
4.0% |
| Drug Ineffective |
4.0% |
| Dyspnoea |
4.0% |
| International Normalised Ratio Abnormal |
4.0% |
| Lung Disorder |
4.0% |
| Mental Status Changes |
4.0% |
| Nodal Arrhythmia |
4.0% |
| Off Label Use |
4.0% |
| Tendon Rupture |
4.0% |
| Xanthopsia |
4.0% |
| Abdominal Pain |
2.0% |
| Acute Pulmonary Oedema |
2.0% |
|
| Concomitant |
| Atrial Fibrillation |
35.6% |
| Product Used For Unknown Indication |
22.4% |
| Cerebrovascular Accident Prophylaxis |
12.7% |
| Anticoagulant Therapy |
3.4% |
| Hypertension |
2.9% |
| Cardiac Disorder |
2.4% |
| Antiplatelet Therapy |
2.0% |
| Arrhythmia |
2.0% |
| Hypothyroidism |
2.0% |
| Trigeminal Neuralgia |
2.0% |
| Back Pain |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Discomfort |
1.5% |
| Lung Disorder |
1.5% |
| Multiple Myeloma |
1.5% |
| Myocardial Infarction |
1.5% |
| Anaphylactic Reaction |
1.0% |
| Atrial Flutter |
1.0% |
| Blood Pressure Abnormal |
1.0% |
| Bronchitis |
1.0% |
|
| Epistaxis |
10.0% |
| Pain |
10.0% |
| Death |
7.5% |
| Gastrointestinal Haemorrhage |
7.5% |
| Haemorrhage Urinary Tract |
7.5% |
| Syncope |
7.5% |
| Incontinence |
5.0% |
| International Normalised Ratio Decreased |
5.0% |
| Lip Oedema |
5.0% |
| Palpitations |
5.0% |
| Somnolence |
5.0% |
| Urinary Tract Infection |
5.0% |
| Atrophic Vulvovaginitis |
2.5% |
| Blood Glucose Increased |
2.5% |
| Cough |
2.5% |
| Dizziness |
2.5% |
| Drug Ineffective |
2.5% |
| Embolic Stroke |
2.5% |
| Gastritis |
2.5% |
| Gingival Bleeding |
2.5% |
|
| Interacting |
| Atrial Fibrillation |
52.9% |
| Drug Use For Unknown Indication |
11.8% |
| Anxiety Disorder |
5.9% |
| Cerebrovascular Accident Prophylaxis |
5.9% |
| Depression |
5.9% |
| Diabetes Mellitus |
5.9% |
| Hypertension |
5.9% |
| Product Used For Unknown Indication |
5.9% |
|
| Serotonin Syndrome |
33.3% |
| Nausea |
16.7% |
| Rhabdomyolysis |
16.7% |
| Thinking Abnormal |
16.7% |
| Torsade De Pointes |
16.7% |
|
